» Articles » PMID: 37009448

Multimodality Neuroimaging in Vascular Mild Cognitive Impairment: A Narrative Review of Current Evidence

Overview
Specialty Geriatrics
Date 2023 Apr 3
PMID 37009448
Authors
Affiliations
Soon will be listed here.
Abstract

The vascular mild cognitive impairment (VaMCI) is generally accepted as the premonition stage of vascular dementia (VaD). However, most studies are focused mainly on VaD as a diagnosis in patients, thus neglecting the VaMCI stage. VaMCI stage, though, is easily diagnosed by vascular injuries and represents a high-risk period for the future decline of patients' cognitive functions. The existing studies in China and abroad have found that magnetic resonance imaging technology can provide imaging markers related to the occurrence and development of VaMCI, which is an important tool for detecting the changes in microstructure and function of VaMCI patients. Nevertheless, most of the existing studies evaluate the information of a single modal image. Due to the different imaging principles, the data provided by a single modal image are limited. In contrast, multi-modal magnetic resonance imaging research can provide multiple comprehensive data such as tissue anatomy and function. Here, a narrative review of published articles on multimodality neuroimaging in VaMCI diagnosis was conducted,and the utilization of certain neuroimaging bio-markers in clinical applications was narrated. These markers include evaluation of vascular dysfunction before tissue damages and quantification of the extent of network connectivity disruption. We further provide recommendations for early detection, progress, prompt treatment response of VaMCI, as well as optimization of the personalized treatment plan.

Citing Articles

Aberrant baseline brain activity and disrupted functional connectivity in patients with vascular cognitive impairment due to cerebral small vessel disease.

Mu R, Yang P, Qin X, Zheng W, Li X, Huang B Front Neurol. 2024; 15:1421283.

PMID: 39022734 PMC: 11252026. DOI: 10.3389/fneur.2024.1421283.

References
1.
Honey C, Sporns O, Cammoun L, Gigandet X, Thiran J, Meuli R . Predicting human resting-state functional connectivity from structural connectivity. Proc Natl Acad Sci U S A. 2009; 106(6):2035-40. PMC: 2634800. DOI: 10.1073/pnas.0811168106. View

2.
Stebbins G, Nyenhuis D, Wang C, Cox J, Freels S, Bangen K . Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008; 39(3):785-93. DOI: 10.1161/STROKEAHA.107.507392. View

3.
Mijajlovic M, Pavlovic A, Brainin M, Heiss W, Quinn T, Ihle-Hansen H . Post-stroke dementia - a comprehensive review. BMC Med. 2017; 15(1):11. PMC: 5241961. DOI: 10.1186/s12916-017-0779-7. View

4.
Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

5.
Nugent A, Martinez A, dAlfonso A, Zarate C, Theodore W . The relationship between glucose metabolism, resting-state fMRI BOLD signal, and GABAA-binding potential: a preliminary study in healthy subjects and those with temporal lobe epilepsy. J Cereb Blood Flow Metab. 2015; 35(4):583-91. PMC: 4420874. DOI: 10.1038/jcbfm.2014.228. View